Phase 3: Weeks 1016 (Precision Phase) Fat loss slows slightly
Originally developed by Novo Nordisk to treat type-2 diabetes, semaglutide, delivered in an injection, has gained global attention for its weight-loss benefits
by contrast, antagonizing NMDA receptors in the hypothalamus has been linked to a reduction in food intake and a decrease in body weight 8
Serious but rare side effects include pancreatitis, gallbladder problems, kidney issues, thyroid cancer risk, and severe allergic reactions
I have very mixed feelings about it
This is especially true if your symptoms are severe, are not improving or begin to significantly impact your quality of life